Common reasons for drug registration rejection in Taiwan include incomplete documentation, non-compliance with Good Manufacturing Practice (GMP), insufficient clinical evidence of safety and efficacy, or discrepancies in foreign clinical data. Applications may also fail due to missing bridging studies or incorrect labeling that does not meet TFDA standards.
